Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

about

Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells.

P2860

Q41072362-1EF32D71-E697-488D-AC5D-0509E230EAFF

P2860

Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

Item

http://www.wikidata.org/entity/Q40928391

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Alleviating Effect of Active H ...... creatic Ductal Adenocarcinoma.

@en

type

Item

label

Alleviating Effect of Active H ...... creatic Ductal Adenocarcinoma.

@en

prefLabel

Alleviating Effect of Active H ...... creatic Ductal Adenocarcinoma.

@en

P1476

Alleviating Effect of Active H ...... creatic Ductal Adenocarcinoma.

@en

P2093

Hiroaki Yanagimoto

http://www.w3.org/2001/XMLSchema#string

Hironori Ryota

http://www.w3.org/2001/XMLSchema#string

Kentaro Inoue

http://www.w3.org/2001/XMLSchema#string

Koji Tsuta

http://www.w3.org/2001/XMLSchema#string

Masanori Kon

http://www.w3.org/2001/XMLSchema#string

Masaya Kotsuka

http://www.w3.org/2001/XMLSchema#string

Satoshi Hirooka

http://www.w3.org/2001/XMLSchema#string

So Yamaki

http://www.w3.org/2001/XMLSchema#string

Sohei Satoi

http://www.w3.org/2001/XMLSchema#string

Taku Michiura

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy

Nationwide survey on complementary and alternative medicine in cancer patients in Japan

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

P304

234-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/01635581.2016.1134597

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26847832

http://www.w3.org/2001/XMLSchema#string

Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

about

P2860

P2860

Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698